These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 9207450

  • 21. Proliferative responses and binding properties of hematopoietic cells transfected with low-affinity receptors for leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor.
    Gearing DP, Ziegler SF, Comeau MR, Friend D, Thoma B, Cosman D, Park L, Mosley B.
    Proc Natl Acad Sci U S A; 1994 Feb 01; 91(3):1119-23. PubMed ID: 8302840
    [Abstract] [Full Text] [Related]

  • 22. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
    Hermanns HM, Radtke S, Haan C, Schmitz-Van de Leur H, Tavernier J, Heinrich PC, Behrmann I.
    J Immunol; 1999 Dec 15; 163(12):6651-8. PubMed ID: 10586060
    [Abstract] [Full Text] [Related]

  • 23. Differential effects of oncostatin M and leukaemia inhibitory factor expression in astrocytoma cells.
    Kasza A, Rogowski K, Kilarski W, Sobota R, Bernas T, Dobrucki J, Travis J, Koj A, Bugno M, Kordula T.
    Biochem J; 2001 Apr 15; 355(Pt 2):307-14. PubMed ID: 11284716
    [Abstract] [Full Text] [Related]

  • 24. Cross-species receptor binding characteristics of human and mouse leukemia inhibitory factor suggest a complex binding interaction.
    Layton MJ, Lock P, Metcalf D, Nicola NA.
    J Biol Chem; 1994 Jun 24; 269(25):17048-55. PubMed ID: 8006010
    [Abstract] [Full Text] [Related]

  • 25. GP130/OSMR is the only LIF/IL-6 family receptor complex to promote osteoblast differentiation of calvaria progenitors.
    Malaval L, Liu F, Vernallis AB, Aubin JE.
    J Cell Physiol; 2005 Aug 24; 204(2):585-93. PubMed ID: 15751050
    [Abstract] [Full Text] [Related]

  • 26. Interleukin-6 family of cytokines induced activation of different functional sites expressed by gp130 transducing protein.
    Chevalier S, Fourcin M, Robledo O, Wijdenes J, Pouplard-Barthelaix A, Gascan H.
    J Biol Chem; 1996 Jun 21; 271(25):14764-72. PubMed ID: 8662918
    [Abstract] [Full Text] [Related]

  • 27. Oncostatin M binds the high-affinity leukemia inhibitory factor receptor.
    Gearing DP, Bruce AG.
    New Biol; 1992 Jan 21; 4(1):61-5. PubMed ID: 1536831
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Oncostatin M (OSM) inhibits the differentiation of pluripotent embryonic stem cells in vitro.
    Rose TM, Weiford DM, Gunderson NL, Bruce AG.
    Cytokine; 1994 Jan 21; 6(1):48-54. PubMed ID: 8003633
    [Abstract] [Full Text] [Related]

  • 31. Inter-species chimeras of leukaemia inhibitory factor define a major human receptor-binding determinant.
    Owczarek CM, Layton MJ, Metcalf D, Lock P, Willson TA, Gough NM, Nicola NA.
    EMBO J; 1993 Sep 21; 12(9):3487-95. PubMed ID: 8253075
    [Abstract] [Full Text] [Related]

  • 32. Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex.
    Pennica D, Shaw KJ, Swanson TA, Moore MW, Shelton DL, Zioncheck KA, Rosenthal A, Taga T, Paoni NF, Wood WI.
    J Biol Chem; 1995 May 05; 270(18):10915-22. PubMed ID: 7738033
    [Abstract] [Full Text] [Related]

  • 33. Different epitopes are required for gp130 activation by interleukin-6, oncostatin M and leukemia inhibitory factor.
    Timmermann A, Pflanz S, Grötzinger J, Küster A, Kurth I, Pitard V, Heinrich PC, Müller-Newen G.
    FEBS Lett; 2000 Feb 25; 468(2-3):120-4. PubMed ID: 10692570
    [Abstract] [Full Text] [Related]

  • 34. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor.
    Nandurkar HH, Hilton DJ, Nathan P, Willson T, Nicola N, Begley CG.
    Oncogene; 1996 Feb 01; 12(3):585-93. PubMed ID: 8637716
    [Abstract] [Full Text] [Related]

  • 35. Oncostatin M-specific receptor expression and function in regulating cell proliferation of normal and malignant mammary epithelial cells.
    Liu J, Hadjokas N, Mosley B, Estrov Z, Spence MJ, Vestal RE.
    Cytokine; 1998 Apr 01; 10(4):295-302. PubMed ID: 9617575
    [Abstract] [Full Text] [Related]

  • 36. Mutations in the immunoglobulin-like domain of gp190, the leukemia inhibitory factor (LIF) receptor, increase or decrease its affinity for LIF.
    Bitard J, Daburon S, Duplomb L, Blanchard F, Vuisio P, Jacques Y, Godard A, Heath JK, Moreau JF, Taupin JL.
    J Biol Chem; 2003 May 02; 278(18):16253-61. PubMed ID: 12601009
    [Abstract] [Full Text] [Related]

  • 37. The upper cytokine-binding module and the Ig-like domain of the leukaemia inhibitory factor (LIF) receptor are sufficient for a functional LIF receptor complex.
    Aasland D, Oppmann B, Grötzinger J, Rose-John S, Kallen KJ.
    J Mol Biol; 2002 Jan 25; 315(4):637-46. PubMed ID: 11812136
    [Abstract] [Full Text] [Related]

  • 38. Mice overexpressing murine oncostatin M (OSM) exhibit changes in hematopoietic and other organs that are distinct from those of mice overexpressing human OSM or bovine OSM.
    Juan TS, Bolon B, Lindberg RA, Sun Y, Van G, Fletcher FA.
    Vet Pathol; 2009 Jan 25; 46(1):124-37. PubMed ID: 19112126
    [Abstract] [Full Text] [Related]

  • 39. Binding interactions of leukemia inhibitory factor and ciliary neurotrophic factor with the different subunits of their high affinity receptors.
    Robledo O, Auguste P, Coupey L, Praloran V, Chevalier S, Pouplard A, Gascan H.
    J Neurochem; 1996 Apr 25; 66(4):1391-9. PubMed ID: 8627290
    [Abstract] [Full Text] [Related]

  • 40. Oncostatin M is a differentiation factor for myeloid leukemia cells.
    Bruce AG, Hoggatt IH, Rose TM.
    J Immunol; 1992 Aug 15; 149(4):1271-5. PubMed ID: 1380037
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.